BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20619680)

  • 1. Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices.
    Pak SW; Uriel N; Takayama H; Cappleman S; Song R; Colombo PC; Charles S; Mancini D; Gillam L; Naka Y; Jorde UP
    J Heart Lung Transplant; 2010 Oct; 29(10):1172-6. PubMed ID: 20619680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of aortic insufficiency in patients supported with continuous flow left ventricular assist devices.
    Soleimani B; Haouzi A; Manoskey A; Stephenson ER; El-Banayosy A; Pae WE
    ASAIO J; 2012; 58(4):326-9. PubMed ID: 22569164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late aortic insufficiency related to poor prognosis during left ventricular assist device support.
    Toda K; Fujita T; Domae K; Shimahara Y; Kobayashi J; Nakatani T
    Ann Thorac Surg; 2011 Sep; 92(3):929-34. PubMed ID: 21871279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical correction of aortic valve insufficiency after left ventricular assist device implantation.
    Atkins BZ; Hashmi ZA; Ganapathi AM; Harrison JK; Hughes GC; Rogers JG; Milano CA
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1247-52. PubMed ID: 23870154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of aortic valve opening in patients with aortic insufficiency after left ventricular assist device implantation.
    da Rocha E Silva JG; Meyer AL; Eifert S; Garbade J; Mohr FW; Strueber M
    Eur J Cardiothorac Surg; 2016 Mar; 49(3):784-7. PubMed ID: 26084757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological analysis of the aortic valve after long-term left ventricular assist device support.
    Hata H; Fujita T; Ishibashi-Ueda H; Nakatani T; Kobayashi J
    Eur J Cardiothorac Surg; 2014 Aug; 46(2):193-7. PubMed ID: 24335262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, significance, and management of aortic insufficiency in continuous flow left ventricular assist device recipients.
    Jorde UP; Uriel N; Nahumi N; Bejar D; Gonzalez-Costello J; Thomas SS; Han J; Morrison KA; Jones S; Kodali S; Hahn RT; Shames S; Yuzefpolskaya M; Colombo P; Takayama H; Naka Y
    Circ Heart Fail; 2014 Mar; 7(2):310-9. PubMed ID: 24415682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insufficiency of the native aortic valve and left ventricular assist system inflow valve after support with an implantable left ventricular assist system: signs, symptoms, and concerns.
    Samuels LE; Thomas MP; Holmes EC; Narula J; Fitzpatrick J; Wood D; Fyfe B; Wechsler AS
    J Thorac Cardiovasc Surg; 2001 Aug; 122(2):380-1. PubMed ID: 11479514
    [No Abstract]   [Full Text] [Related]  

  • 11. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation.
    Uriel N; Pak SW; Jorde UP; Jude B; Susen S; Vincentelli A; Ennezat PV; Cappleman S; Naka Y; Mancini D
    J Am Coll Cardiol; 2010 Oct; 56(15):1207-13. PubMed ID: 20598466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aortic valve opening and thrombotic events with continuous-flow left ventricular assist devices.
    Saeed O; Maybaum S; Alessandro DD; Goldstein DJ; Patel SR
    J Heart Lung Transplant; 2014 Jan; 33(1):109-12. PubMed ID: 23937883
    [No Abstract]   [Full Text] [Related]  

  • 13. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
    Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
    Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pulsatile- and continuous-flow left ventricular assist devices on left ventricular unloading.
    Garcia S; Kandar F; Boyle A; Colvin-Adams M; Lliao K; Joyce L; John R
    J Heart Lung Transplant; 2008 Mar; 27(3):261-7. PubMed ID: 18342746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of aortic valve insufficiency in patients supported by long-term continuous flow left ventricular assist devices.
    Morgan JA; Brewer RJ; Nemeh HW; Henry SE; Neha N; Williams CT; Lanfear DE; Tita C; Paone G
    Ann Thorac Surg; 2012 Nov; 94(5):1710-2. PubMed ID: 23098948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consequences of aortic insufficiency during long-term axial continuous-flow left ventricular assist device support.
    Cowger JA; Aaronson KD; Romano MA; Haft J; Pagani FD
    J Heart Lung Transplant; 2014 Dec; 33(12):1233-40. PubMed ID: 25108909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of late aortic insufficiency with continuous flow left ventricular assist deviceā€ .
    Hiraoka A; Cohen JE; Shudo Y; MacArthur JW; Howard JL; Fairman AS; Atluri P; Kirkpatrick JN; Woo YJ
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):400-6. PubMed ID: 25653250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved durability of the HeartMate XVE left ventricular assist device provides safe mechanical support up to 1 year but is associated with high risk of device failure in the second year.
    Martin J; Friesewinkel O; Benk C; Sorg S; Schultz S; Beyersdorf F
    J Heart Lung Transplant; 2006 Apr; 25(4):384-90. PubMed ID: 16563965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.
    Kamdar F; Boyle A; Liao K; Colvin-adams M; Joyce L; John R
    J Heart Lung Transplant; 2009 Apr; 28(4):352-9. PubMed ID: 19332262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.